Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma.

Peter Downie et al. published in the Journal of Pediatric Hematology/Oncology.

Read article here.